JP2022511554A5 - - Google Patents
Info
- Publication number
- JP2022511554A5 JP2022511554A5 JP2021532308A JP2021532308A JP2022511554A5 JP 2022511554 A5 JP2022511554 A5 JP 2022511554A5 JP 2021532308 A JP2021532308 A JP 2021532308A JP 2021532308 A JP2021532308 A JP 2021532308A JP 2022511554 A5 JP2022511554 A5 JP 2022511554A5
- Authority
- JP
- Japan
- Prior art keywords
- solid
- crystalline form
- pharmaceutical composition
- particle size
- methylisoindigo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024141101A JP2024170448A (ja) | 2018-12-07 | 2024-08-22 | メイソインジゴの多形体およびメイソインジゴの改変された製剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862776965P | 2018-12-07 | 2018-12-07 | |
| US62/776,965 | 2018-12-07 | ||
| PCT/US2019/062704 WO2020117487A1 (en) | 2018-12-07 | 2019-11-21 | Polymorphic form of meisoindigo and modified formulation of meisoindigo |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024141101A Division JP2024170448A (ja) | 2018-12-07 | 2024-08-22 | メイソインジゴの多形体およびメイソインジゴの改変された製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022511554A JP2022511554A (ja) | 2022-01-31 |
| JP2022511554A5 true JP2022511554A5 (https=) | 2022-11-28 |
Family
ID=70974812
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021532308A Pending JP2022511554A (ja) | 2018-12-07 | 2019-11-21 | メイソインジゴの多形体およびメイソインジゴの改変された製剤 |
| JP2024141101A Pending JP2024170448A (ja) | 2018-12-07 | 2024-08-22 | メイソインジゴの多形体およびメイソインジゴの改変された製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024141101A Pending JP2024170448A (ja) | 2018-12-07 | 2024-08-22 | メイソインジゴの多形体およびメイソインジゴの改変された製剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20220009889A1 (https=) |
| EP (1) | EP3891141A4 (https=) |
| JP (2) | JP2022511554A (https=) |
| KR (1) | KR20210102335A (https=) |
| CN (2) | CN118515598A (https=) |
| CA (1) | CA3121726A1 (https=) |
| IL (1) | IL283703A (https=) |
| MX (1) | MX2021006464A (https=) |
| WO (1) | WO2020117487A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7851300B2 (ja) | 2021-04-21 | 2026-04-24 | 住友化学株式会社 | 縮合複素環化合物を用いる衛生害虫の防除方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS617254A (ja) * | 1984-06-20 | 1986-01-13 | Isukura Sangyo Kk | ビスインドリノンおよびそれを主成分とする制癌剤 |
| US20050154046A1 (en) * | 2004-01-12 | 2005-07-14 | Longgui Wang | Methods of treating an inflammatory-related disease |
| US7582670B2 (en) * | 2001-12-13 | 2009-09-01 | Natrogen Therapeutics, Inc. | Methods of treating an inflammatory-related disease |
| CA2469649C (en) * | 2001-12-13 | 2011-05-03 | Natrogen Therapeutics, Inc. | Derivatives of isoindigo, indigo and indirubin and use in treating cancer |
| CA2868302A1 (en) * | 2012-03-23 | 2013-09-26 | Dennis M. Brown | Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo |
| PT106237B (pt) * | 2012-03-30 | 2015-03-19 | Hovione Farmaci Ncia S A | Produção de partículas substancialmente monodispersas utilizando moagem e separação por membranas |
| CN106176720A (zh) * | 2016-08-17 | 2016-12-07 | 武汉大学 | 甲异靛在制备抗炎药物中的应用 |
-
2019
- 2019-11-21 JP JP2021532308A patent/JP2022511554A/ja active Pending
- 2019-11-21 US US17/298,528 patent/US20220009889A1/en not_active Abandoned
- 2019-11-21 CN CN202410495669.6A patent/CN118515598A/zh active Pending
- 2019-11-21 MX MX2021006464A patent/MX2021006464A/es unknown
- 2019-11-21 EP EP19892926.7A patent/EP3891141A4/en active Pending
- 2019-11-21 CA CA3121726A patent/CA3121726A1/en active Pending
- 2019-11-21 KR KR1020217021317A patent/KR20210102335A/ko not_active Ceased
- 2019-11-21 CN CN201980090936.9A patent/CN113365990A/zh active Pending
- 2019-11-21 WO PCT/US2019/062704 patent/WO2020117487A1/en not_active Ceased
-
2021
- 2021-06-03 IL IL283703A patent/IL283703A/en unknown
-
2024
- 2024-08-22 JP JP2024141101A patent/JP2024170448A/ja active Pending
- 2024-11-21 US US18/955,955 patent/US20250084035A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101679218B (zh) | 晶体米诺环素碱及其制备方法 | |
| JP6317775B2 (ja) | ｃ−Ｍｅｔモジュレーターの使用方法 | |
| CN1227233C (zh) | 纯晶形的5－氯－3－(4－甲磺酰基苯基)－6′－甲基－[2,3′]联吡啶及其合成方法 | |
| JP6457658B2 (ja) | 安定した、溶媒和物が含まれないアプレミラスト結晶形ｉｉ、及びその製造方法 | |
| JP2010132687A (ja) | １−４−（５−シアノインドール−３−イル）ブチル−４−（２−カルバモイルベンゾフラン−５−イル）ピペラジン塩酸塩の多形相 | |
| JP2011513485A5 (https=) | ||
| TW201302709A (zh) | 治療癌症的方法 | |
| JP2023509628A5 (https=) | ||
| WO2017107972A1 (zh) | 一种选择性s1p1受体激动剂的新晶型及其制备方法 | |
| KR20150036336A (ko) | 타이로신 키나제 억제제 다이말리에이트의 결정형 아이 및 그의 제조 방법 | |
| CN102827153A (zh) | 阿齐沙坦的晶型及其制备方法 | |
| CN1578772A (zh) | 太尔密沙登的晶状钠盐及其作为血管紧张素的拮抗药的用途 | |
| CN105324375A (zh) | 盐酸尼洛替尼的多晶型形式 | |
| WO2016107289A1 (zh) | 制备索非布韦晶型6的方法 | |
| JP2007520546A (ja) | モンテルカストナトリウムの安定な非晶質性形態 | |
| KR102657147B1 (ko) | 빌라스틴의 결정형 및 그의 제조 방법 | |
| CN104098570A (zh) | 替卡格雷晶型及其制备方法和用途 | |
| JP2022511554A5 (https=) | ||
| CN107698574B (zh) | 一种高纯度阿瑞匹坦的精制制备工艺 | |
| CN108112252A (zh) | 制备阿地溴铵的方法 | |
| CN102282125A (zh) | 新方法和纯的多晶型物 | |
| CN103936808A (zh) | 17β雌二醇的异烟酰胺共结晶及其制备方法和应用 | |
| CN104379557B (zh) | 阿戈美拉汀晶型i的制备方法 | |
| JP2008505935A5 (https=) | ||
| JP2006151977A (ja) | （ｒ）−３−［［（４−フルオロフェニル）スルホニル］アミノ］−１，２，３，４−テトラヒドロ−９ｈ−カルバゾール−９−プロパン酸（ラマトロバン）の熱力学的に安定な形態の結晶の製造方法 |